Gsk (GSK) Research & Development (2016 - 2025)
Historic Research & Development for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$2.3 billion.
- Gsk's Research & Development fell 2019.66% to -$2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.0 billion, marking a year-over-year decrease of 1302.75%. This contributed to the annual value of $8.2 billion for FY2024, which is 570.95% up from last year.
- According to the latest figures from Q3 2025, Gsk's Research & Development is -$2.3 billion, which was down 2019.66% from -$2.7 billion recorded in Q2 2025.
- Gsk's 5-year Research & Development high stood at -$1.5 billion for Q1 2021, and its period low was -$8.2 billion during Q4 2024.
- For the 5-year period, Gsk's Research & Development averaged around -$2.7 billion, with its median value being -$1.9 billion (2021).
- Within the past 5 years, the most significant YoY rise in Gsk's Research & Development was 1873.64% (2022), while the steepest drop was 24703.54% (2022).
- Quarter analysis of 5 years shows Gsk's Research & Development stood at -$1.9 billion in 2021, then plummeted by 247.04% to -$6.4 billion in 2022, then decreased by 19.99% to -$7.7 billion in 2023, then fell by 6.37% to -$8.2 billion in 2024, then skyrocketed by 72.27% to -$2.3 billion in 2025.
- Its Research & Development stands at -$2.3 billion for Q3 2025, versus -$2.7 billion for Q2 2025 and -$1.8 billion for Q1 2025.